{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/dea/actions/recent","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.federalregister.gov/agencies/drug-enforcement-administration","generated_at":"2026-11-16T04:54:56.065Z"},"count":50,"items":[{"document_number":"2026-23075","title":"Schedules of Controlled Substances: Placement of Oveporexton in Schedule IV","publication_date":"2026-11-12","fr_type":"Rule","action_label":"Interim final rule; request for comments.","category":"scheduling","citation":"91 FR 72775","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/11/12/2026-23075/schedules-of-controlled-substances-placement-of-oveporexton-in-schedule-iv","canonical_url":"https://api.morvs.ai/dea-action/2026-23075"},{"document_number":"2026-23006","title":"Importer of Controlled Substances Application: NSI Lab Solutions LLC","publication_date":"2026-11-12","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 72916","party_name":"NSI Lab Solutions LLC","html_url":"https://www.federalregister.gov/documents/2026/11/12/2026-23006/importer-of-controlled-substances-application-nsi-lab-solutions-llc","canonical_url":"https://api.morvs.ai/dea-action/2026-23006"},{"document_number":"2026-22955","title":"Troy R. Lehman, D.O.; Decision and Order","publication_date":"2026-11-12","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 72913","party_name":"Troy R. Lehman, D.O.","html_url":"https://www.federalregister.gov/documents/2026/11/12/2026-22955/troy-r-lehman-do-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-22955"},{"document_number":"2026-22954","title":"Traci B. Lujan, A.P.R.N.; Decision and Order","publication_date":"2026-11-12","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 72912","party_name":"Traci B. Lujan, A.P.R.N.","html_url":"https://www.federalregister.gov/documents/2026/11/12/2026-22954/traci-b-lujan-aprn-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-22954"},{"document_number":"2026-22843","title":"Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027","publication_date":"2026-11-10","fr_type":"Notice","action_label":"Notice with request for comments.","category":"quota","citation":"91 FR 72566","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/11/10/2026-22843/proposed-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment-of","canonical_url":"https://api.morvs.ai/dea-action/2026-22843"},{"document_number":"2026-22842","title":"Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h)","publication_date":"2026-11-10","fr_type":"Notice","action_label":"Final order.","category":"quota","citation":"91 FR 72564","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/11/10/2026-22842/adjustment-to-the-2026-aggregate-production-quota-for-dl-amphetamine-d-amphetamine-for-sale","canonical_url":"https://api.morvs.ai/dea-action/2026-22842"},{"document_number":"2026-22717","title":"Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance","publication_date":"2026-11-06","fr_type":"Rule","action_label":"Final rule.","category":"other","citation":"91 FR 70009","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/11/06/2026-22717/specific-listing-for-3-chloromethcathinone-a-currently-controlled-schedule-i-substance","canonical_url":"https://api.morvs.ai/dea-action/2026-22717"},{"document_number":"2026-22556","title":"Bulk Manufacturer of Controlled Substances Application: Navinta LLC","publication_date":"2026-11-05","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 69885","party_name":"Navinta LLC","html_url":"https://www.federalregister.gov/documents/2026/11/05/2026-22556/bulk-manufacturer-of-controlled-substances-application-navinta-llc","canonical_url":"https://api.morvs.ai/dea-action/2026-22556"},{"document_number":"2026-22555","title":"Importer of Controlled Substances Application: Diamond Animal Health, Inc.","publication_date":"2026-11-05","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 69885","party_name":"Diamond Animal Health, Inc.","html_url":"https://www.federalregister.gov/documents/2026/11/05/2026-22555/importer-of-controlled-substances-application-diamond-animal-health-inc","canonical_url":"https://api.morvs.ai/dea-action/2026-22555"},{"document_number":"2026-22553","title":"Importer of Controlled Substances Application: Noramco","publication_date":"2026-11-05","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 69884","party_name":"Noramco","html_url":"https://www.federalregister.gov/documents/2026/11/05/2026-22553/importer-of-controlled-substances-application-noramco","canonical_url":"https://api.morvs.ai/dea-action/2026-22553"},{"document_number":"2026-22484","title":"Technical Amendment to the Regulation Regarding Amendments to Applications","publication_date":"2026-11-04","fr_type":"Rule","action_label":"Final rule; technical amendment.","category":"other","citation":"91 FR 69500","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/11/04/2026-22484/technical-amendment-to-the-regulation-regarding-amendments-to-applications","canonical_url":"https://api.morvs.ai/dea-action/2026-22484"},{"document_number":"2026-22289","title":"Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences","publication_date":"2026-11-02","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 68984","party_name":"AJNA Biosciences","html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22289/bulk-manufacturer-of-controlled-substances-application-ajna-biosciences","canonical_url":"https://api.morvs.ai/dea-action/2026-22289"},{"document_number":"2026-22288","title":"Importer of Controlled Substances Application: Globyz Pharma LLC","publication_date":"2026-11-02","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 68984","party_name":"Globyz Pharma LLC","html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22288/importer-of-controlled-substances-application-globyz-pharma-llc","canonical_url":"https://api.morvs.ai/dea-action/2026-22288"},{"document_number":"2026-22285","title":"Conforming Amendment Regarding the Criminal Law Technical Amendments Act of 2002","publication_date":"2026-11-02","fr_type":"Rule","action_label":"Final rule.","category":"other","citation":"91 FR 68885","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/11/02/2026-22285/conforming-amendment-regarding-the-criminal-law-technical-amendments-act-of-2002","canonical_url":"https://api.morvs.ai/dea-action/2026-22285"},{"document_number":"2026-22208","title":"Schedules of Controlled Substances: Placement of Centanafadine in Schedule III","publication_date":"2026-10-30","fr_type":"Rule","action_label":"Interim final rule; request for comments.","category":"scheduling","citation":"91 FR 68470","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/30/2026-22208/schedules-of-controlled-substances-placement-of-centanafadine-in-schedule-iii","canonical_url":"https://api.morvs.ai/dea-action/2026-22208"},{"document_number":"2026-22048","title":"Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.","publication_date":"2026-10-29","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 68166","party_name":"Sigma Aldrich Research Biochemicals, Inc.","html_url":"https://www.federalregister.gov/documents/2026/10/29/2026-22048/bulk-manufacturer-of-controlled-substances-application-sigma-aldrich-research-biochemicals-inc","canonical_url":"https://api.morvs.ai/dea-action/2026-22048"},{"document_number":"2026-21799","title":"Vida Janson, M.D.; Decision and Order","publication_date":"2026-10-26","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 67331","party_name":"Vida Janson, M.D.","html_url":"https://www.federalregister.gov/documents/2026/10/26/2026-21799/vida-janson-md-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21799"},{"document_number":"2026-21725","title":"Barry Backiewicz, D.D.S.; Decision and Order","publication_date":"2026-10-26","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 67333","party_name":"Barry Backiewicz, D.D.S.","html_url":"https://www.federalregister.gov/documents/2026/10/26/2026-21725/barry-backiewicz-dds-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21725"},{"document_number":"2026-21415","title":"Peter Michael Wills, D.D.S.; Decision and Order","publication_date":"2026-10-20","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 66361","party_name":"Peter Michael Wills, D.D.S.","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21415/peter-michael-wills-dds-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21415"},{"document_number":"2026-21414","title":"Jan Pijanowski, M.D.; Decision and Order","publication_date":"2026-10-20","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 66362","party_name":"Jan Pijanowski, M.D.","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21414/jan-pijanowski-md-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21414"},{"document_number":"2026-21413","title":"Jefferson Burroughs, M.D.; Decision and Order","publication_date":"2026-10-20","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 66360","party_name":"Jefferson Burroughs, M.D.","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21413/jefferson-burroughs-md-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21413"},{"document_number":"2026-21410","title":"Youmna Abdulhadi, M.D.; Decision and Order","publication_date":"2026-10-20","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 66363","party_name":"Youmna Abdulhadi, M.D.","html_url":"https://www.federalregister.gov/documents/2026/10/20/2026-21410/youmna-abdulhadi-md-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21410"},{"document_number":"2026-21370","title":"Importer of Controlled Substances Application: Organic Standards Solutions International, LLC","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66153","party_name":"Organic Standards Solutions International, LLC","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21370/importer-of-controlled-substances-application-organic-standards-solutions-international-llc","canonical_url":"https://api.morvs.ai/dea-action/2026-21370"},{"document_number":"2026-21369","title":"Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66151","party_name":"Janssen Pharmaceuticals, Inc.","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21369/bulk-manufacturer-of-controlled-substances-application-janssen-pharmaceuticals-inc","canonical_url":"https://api.morvs.ai/dea-action/2026-21369"},{"document_number":"2026-21368","title":"Bulk Manufacturer of Controlled Substances Application: Groff Health Inc","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66154","party_name":"Groff Health Inc","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21368/bulk-manufacturer-of-controlled-substances-application-groff-health-inc","canonical_url":"https://api.morvs.ai/dea-action/2026-21368"},{"document_number":"2026-21367","title":"Importer of Controlled Substances Application: Groff NA Hemplex LLC","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66155","party_name":"Groff NA Hemplex LLC","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21367/importer-of-controlled-substances-application-groff-na-hemplex-llc","canonical_url":"https://api.morvs.ai/dea-action/2026-21367"},{"document_number":"2026-21360","title":"Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66151","party_name":"Scottsdale Research Institute","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21360/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute","canonical_url":"https://api.morvs.ai/dea-action/2026-21360"},{"document_number":"2026-21359","title":"Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research University of Mississippi/NCNPR","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66152","party_name":"National Center for Natural Products Research University of Mississippi/NCNPR","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21359/bulk-manufacturer-of-controlled-substances-application-national-center-for-natural-products-research","canonical_url":"https://api.morvs.ai/dea-action/2026-21359"},{"document_number":"2026-21358","title":"Importer of Controlled Substances Application: National Center for Natural Products Research","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66154","party_name":"National Center for Natural Products Research","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21358/importer-of-controlled-substances-application-national-center-for-natural-products-research","canonical_url":"https://api.morvs.ai/dea-action/2026-21358"},{"document_number":"2026-21355","title":"Importer of Controlled Substances Application: Groff Health Inc.","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66152","party_name":"Groff Health Inc.","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21355/importer-of-controlled-substances-application-groff-health-inc","canonical_url":"https://api.morvs.ai/dea-action/2026-21355"},{"document_number":"2026-21354","title":"Importer of Controlled Substances Application: DMS Pharmaceutical Group","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66155","party_name":"DMS Pharmaceutical Group","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21354/importer-of-controlled-substances-application-dms-pharmaceutical-group","canonical_url":"https://api.morvs.ai/dea-action/2026-21354"},{"document_number":"2026-21353","title":"Importer of Controlled Substances Application: Halo Pharmaceutical Inc.","publication_date":"2026-10-19","fr_type":"Notice","action_label":"Notice of application.","category":"application","citation":"91 FR 66153","party_name":"Halo Pharmaceutical Inc.","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21353/importer-of-controlled-substances-application-halo-pharmaceutical-inc","canonical_url":"https://api.morvs.ai/dea-action/2026-21353"},{"document_number":"2026-21258","title":"Muhamad Aly Rifai, M.D.; Decision and Order","publication_date":"2026-10-19","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 66156","party_name":"Muhamad Aly Rifai, M.D.","html_url":"https://www.federalregister.gov/documents/2026/10/19/2026-21258/muhamad-aly-rifai-md-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-21258"},{"document_number":"2026-20943","title":"Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I","publication_date":"2026-10-14","fr_type":"Proposed Rule","action_label":"Proposed amendment; notice of intent.","category":"scheduling","citation":"91 FR 65370","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/14/2026-20943/schedules-of-controlled-substances-temporary-placement-of-7--hydroxymitragynine-and-mitragynine","canonical_url":"https://api.morvs.ai/dea-action/2026-20943"},{"document_number":"2026-20942","title":"Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I","publication_date":"2026-10-14","fr_type":"Proposed Rule","action_label":"Proposed amendment; notice of intent.","category":"scheduling","citation":"91 FR 65381","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/14/2026-20942/schedules-of-controlled-substances-temporary-placement-of-mgm-15-and-mgm-16-in-schedule-i","canonical_url":"https://api.morvs.ai/dea-action/2026-20942"},{"document_number":"2026-20937","title":"Katherine Curtis, N.P.; Decision and Order","publication_date":"2026-10-14","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 65259","party_name":"Katherine Curtis, N.P.","html_url":"https://www.federalregister.gov/documents/2026/10/14/2026-20937/katherine-curtis-np-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20937"},{"document_number":"2026-20757","title":"Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products","publication_date":"2026-10-09","fr_type":"Rule","action_label":"Final determination.","category":"other","citation":"91 FR 64618","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20757/schedules-of-controlled-substances-removal-of-exemption-status-for-inactive-butalbital-products","canonical_url":"https://api.morvs.ai/dea-action/2026-20757"},{"document_number":"2026-20751","title":"Alexandra R. Lovec, A.P.R.N.; Decision and Order","publication_date":"2026-10-09","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 64685","party_name":"Alexandra R. Lovec, A.P.R.N.","html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20751/alexandra-r-lovec-aprn-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20751"},{"document_number":"2026-20750","title":"L Krenk DBA Maui Clinic Pharmacy; Decision and Order","publication_date":"2026-10-09","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 64689","party_name":"L Krenk DBA Maui Clinic Pharmacy","html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20750/l-krenk-dba-maui-clinic-pharmacy-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20750"},{"document_number":"2026-20749","title":"Vladimir Romaniv, P.A.; Decision and Order","publication_date":"2026-10-09","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 64679","party_name":"Vladimir Romaniv, P.A.","html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20749/vladimir-romaniv-pa-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20749"},{"document_number":"2026-20748","title":"Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction","publication_date":"2026-10-09","fr_type":"Rule","action_label":"Correcting amendment.","category":"scheduling","citation":"91 FR 64617","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/09/2026-20748/schedules-of-controlled-substances-placement-of-o-desmethyltramadol-in-schedule-i-correction","canonical_url":"https://api.morvs.ai/dea-action/2026-20748"},{"document_number":"2026-20553","title":"Decision and Order: Medpharm Research, LLC","publication_date":"2026-10-07","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 64176","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/07/2026-20553/decision-and-order-medpharm-research-llc","canonical_url":"https://api.morvs.ai/dea-action/2026-20553"},{"document_number":"2026-20552","title":"Wellwise Pharmacy Inc.; Decision and Order","publication_date":"2026-10-07","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 64162","party_name":"Wellwise Pharmacy Inc.","html_url":"https://www.federalregister.gov/documents/2026/10/07/2026-20552/wellwise-pharmacy-inc-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20552"},{"document_number":"2026-20535","title":"Arenbii Pharmacy LLC; Decision and Order","publication_date":"2026-10-07","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 64170","party_name":"Arenbii Pharmacy LLC","html_url":"https://www.federalregister.gov/documents/2026/10/07/2026-20535/arenbii-pharmacy-llc-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20535"},{"document_number":"2026-20533","title":"Mark Allen, D.D.S.; Correction to Rescission of Final Agency Action and Withdrawal of Order To Show Cause","publication_date":"2026-10-07","fr_type":"Notice","action_label":null,"category":"other","citation":"91 FR 64170","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/07/2026-20533/mark-allen-dds-correction-to-rescission-of-final-agency-action-and-withdrawal-of-order-to-show-cause","canonical_url":"https://api.morvs.ai/dea-action/2026-20533"},{"document_number":"2026-20227","title":"St. Michael's Pharmacy; Decision and Order","publication_date":"2026-10-02","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 62754","party_name":"St. Michael's Pharmacy","html_url":"https://www.federalregister.gov/documents/2026/10/02/2026-20227/st-michaels-pharmacy-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20227"},{"document_number":"2026-20226","title":"By Grace Inc. Counseling Services; Decision and Order","publication_date":"2026-10-02","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 62748","party_name":"By Grace Inc. Counseling Services","html_url":"https://www.federalregister.gov/documents/2026/10/02/2026-20226/by-grace-inc-counseling-services-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-20226"},{"document_number":"2026-20084","title":"Extension of Reexportation Period.","publication_date":"2026-10-01","fr_type":"Proposed Rule","action_label":"Notice of Proposed Rulemaking.","category":"other","citation":"91 FR 62357","party_name":null,"html_url":"https://www.federalregister.gov/documents/2026/10/01/2026-20084/extension-of-reexportation-period","canonical_url":"https://api.morvs.ai/dea-action/2026-20084"},{"document_number":"2026-19844","title":"Angela Turner-Brown, N.P.; Decision and Order","publication_date":"2026-09-29","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 61442","party_name":"Angela Turner-Brown, N.P.","html_url":"https://www.federalregister.gov/documents/2026/09/29/2026-19844/angela-turner-brown-np-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-19844"},{"document_number":"2026-19842","title":"JT Medical, LLC; Decision and Order","publication_date":"2026-09-29","fr_type":"Notice","action_label":null,"category":"enforcement","citation":"91 FR 61446","party_name":"JT Medical, LLC","html_url":"https://www.federalregister.gov/documents/2026/09/29/2026-19842/jt-medical-llc-decision-and-order","canonical_url":"https://api.morvs.ai/dea-action/2026-19842"}]}